Elevated VCAM1 levels have been reported in patients with lung cancer, RA, and PD compared to their age-matched healthy controls (Navarro-Hernández et al., 2009; Tas et al., 2014; Perner et al., 2019). Here, VCAM1 is linked to lung carcinoma.